Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
16.09.24
/
50%
€68.00
Target price
16.09.25
€116.86
Performance (%)
0.00%
Price
17.09.24
€68.00
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald is currently unchanged from the start price. This prediction currently runs until 16.09.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intra-Cellular Therapies Inc. | 0.00% |
iShares Core DAX® | 1.887% |
iShares Nasdaq 100 | 2.316% |
iShares Nikkei 225® | 1.134% |
iShares S&P 500 | 1.821% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $130.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
08.08.24
08.08.24
€119.16
08.08.25
08.08.25
-0.73%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
14.06.24
14.06.24
€112.19
14.06.25
14.06.25
7.09%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
-0.73%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
4.94%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
14.48%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.30
03.11.23
03.11.23
€94.07
03.11.24
03.11.24
30.60%
17.09.24
17.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24